Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$192,950
in 1 filing, $193K under 10b5-1 plans

Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Meek David D. −$193K Director sold 23% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-08 Abi-Saab Walid Chief Medical Officer Exercise or conversion 10b5-1 +25,000 $5.59 $140K 214,669
2026-05-08 Abi-Saab Walid Chief Medical Officer Sale 10b5-1 −25,000 $25.10 $628K 189,669
2026-05-08 Abi-Saab Walid Chief Medical Officer Sale 10b5-1 −20,000 $25.00 $500K 169,669
2026-05-08 Abi-Saab Walid Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −25,000 60,500
2026-03-04 O'Keefe Kylie Chief Customer & Strat Officer Grant or award +19,800 124,800
2026-03-04 O'Keefe Kylie Chief Customer & Strat Officer Grant or award · Stock Option (Right to Buy) +31,900 31,900
2026-03-04 Kapusta Matthew C CEO, Managing Director Grant or award +70,600 675,239
2026-03-04 Kapusta Matthew C CEO, Managing Director Sale −14,581 $9.06 $132K 660,658
2026-03-04 Kapusta Matthew C CEO, Managing Director Grant or award · Stock Option (Right to Buy) +113,800 113,800
2026-03-04 Abi-Saab Walid Chief Medical Officer Grant or award +41,700 190,477
2026-03-04 Abi-Saab Walid Chief Medical Officer Sale −808 $9.06 $7K 189,669
2026-03-04 Abi-Saab Walid Chief Medical Officer Grant or award · Stock Option (Right to Buy) +67,200 67,200
2026-03-04 Potts Jeannette Chief Legal Officer Grant or award +35,400 141,895
2026-03-04 Potts Jeannette Chief Legal Officer Sale −3,412 $9.06 $31K 138,483
2026-03-04 Potts Jeannette Chief Legal Officer Grant or award · Stock Option (Right to Buy) +57,200 57,200
2026-03-04 KLEMT CHRISTIAN Chief Financial Officer Grant or award +39,600 238,581
2026-03-04 KLEMT CHRISTIAN Chief Financial Officer Sale −12,000 $9.06 $109K 226,581
2026-03-04 KLEMT CHRISTIAN Chief Financial Officer Grant or award · Stock Option (Right to Buy) +63,900 63,900
2026-03-02 Kapusta Matthew C CEO, Managing Director Sale −34,437 $9.95 $343K 604,639
2026-03-02 KLEMT CHRISTIAN Chief Financial Officer Sale −12,532 $9.95 $125K 198,981

Page 5 of 13 · 251 trades